AGCJ
GCVRZ

Alden Global Capital (Jersey)’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Alden Global Capital (Jersey)’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,251,300
Closed -$425K – 40
2013
Q4 		$425K Buy
+1,251,300
New +$1.51M 0.11% 35

Other funds holding GCVRZ

FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alden Global Capital (Jersey)'s GCVRZ Position: Q1 2014 in Review

Alden Global Capital (Jersey) sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2014, closing a stake of 1,251,300 shares — an estimated $425K sold.

Alden Global Capital (Jersey) first reported a position in GCVRZ in Q4 2013 and held it in 1 quarter. The position peaked at $425K in Q4 2013. 125 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2014.

  • Alden Global Capital (Jersey) reported no remaining Sanofi Contingent Value Rights position as of Q1 2014 after selling out during the quarter.
  • Alden Global Capital (Jersey) sold 1,251,300 Sanofi Contingent Value Rights shares in Q1 2014, an estimated $425K.
  • Alden Global Capital (Jersey) first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 1 quarter.
  • Alden Global Capital (Jersey)'s Sanofi Contingent Value Rights position peaked at $425K in Q4 2013.
  • 125 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2014.

Based on Alden Global Capital (Jersey)'s 13F filing for Q1 2014, filed 15 May 2014.